FDA discloses focus of Advisory Committee meeting on insulin degludec and insulin degludec/insulin aspart
25 October 2012 | By Novo Nordisk
“This meeting will focus on the cardiovascular safety of two products..."
List view / Grid view
News
The British Laboratory Managers Association to launch at LAB INNOVATIONS
24 October 2012 | By Energy PR
The British Laboratory Managers Association is being launched by GAMBICA...
Abbott’s ALK test is now available in Europe as a companion diagnostic test to aid in identifying patients for targeted lung cancer therapy
24 October 2012 | By Abbott
ALK test now available in Europe...
Pfizer’s XALKORI® receives conditional marketing authorization from the European Commission
24 October 2012 | By Pfizer
Conditional marketing authorization for XALKORI® in the EU granted...
Abbott announces data evaluating reduction of steroid usage with HUMIRA® (Adalimumab)
24 October 2012 | By Abbott
"These data suggest that adalimumab-treated patients were able to reduce steroid usage..."
Results from new Phase III study amongst women for corifollitropin alfa, an investigational fertility treatment for controlled ovarian stimulation
23 October 2012 | By Merck
New Phase III study presented...
Abbott announces new data evaluating mucosal healing with HUMIRA® (Adalimumab)
23 October 2012 | By Abbott
Results from a post-hoc sub-analysis...
AstraZeneca and Ironwood announce linaclotide collaboration for China
23 October 2012 | By AstraZeneca
AstraZeneca and Ironwood Pharmaceuticals, Inc. announced an agreement to co-develop and co-commercialise Ironwood’s linaclotide...
Rapid, high throughput preformulation with Avacta’s Optim® 1000
23 October 2012 | By kdm communications limited
Avacta Analytical’s Optim® 1000 is proving a valuable asset to scientists at the MVSC, University of Kansas, USA...
Lonza and OncoMed Pharmaceuticals sign a process development and manufacturing collaboration and multi-product GS license agreement
Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.
Abbott announces three-year long-term data evaluating efficacy with HUMIRA® (Adalimumab)
22 October 2012 | By Abbott
Results from an analysis of three-year long-term data...
Results from five phase III studies presented for GSK’s two candidate quadrivalent influenza vaccines
22 October 2012 | By GlaxoSmithKline
Results from five Phase III studies were presented at the IVW congress...
Pfizer to acquire NextWave Pharmaceuticals, Inc.
22 October 2012 | By Pfizer
Pfizer has announced its intention to acquire NextWave Pharmaceuticals...
Phase IIa laquinimod trial results show positive data for potential use in active crohn’s disease
22 October 2012 | By Teva Pharmaceutical Industries Ltd
TEVA and Active Biotech announced the presentation of Phase IIa clinical data...
Sirius Analytical product launch: Novel particle size analysis and digital image analysis combined
22 October 2012 | By Sirius Analytical Instruments Ltd
Sirius Analytical Instruments Ltd announces the introduction of a new product...
